Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Nov 13, 2024 1:27pm
RE:RE:RE:RE:Acquistion
He is no troll. That was me that posted purchase price, it was at the end of the NR and may have been overlooked. We all overlook things sometimes. On the topic of this acquisition, it looks
...more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 13, 2024 11:26am
RE:RE:RE:Acquistion
lscfa must be a troll, because you effortlessly switched from complaining about revenues to purchase price.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Nov 12, 2024 11:18pm
RE:RE:RE:RE:Acquistion
Subject to adjustments set out in the Term Sheet, the aggregate purchase price expected to be paid by the Company for the Purchased Shares shall consist of the following: (i) approximately $200,000 in
...more
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 12, 2024 10:28pm
RE:RE:RE:Acquistion
Should read almost all co.s include in NRs about acquistions some metrics so investors can determine if co paid too much.
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 12, 2024 10:11pm
RE:RE:Acquistion
Total bs. Almost all co. NRs about acquistions include a purchase price so investors can determine if too much was paid.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 12, 2024 9:46pm
FLE for the treatment of acute 2nd degree burns
The more I search the more I find interesting study and article about FB/FLE...this one from 'Military Medicine' that goes back to 2021 -- it looks like we are in the early stage of this
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 12, 2024 9:23pm
Fluorescence Biomodulation -- study (2020)
It looks like FB technology is already being use by veterinarians to treat wounds, see link to study from 2019/20; Wound healing using FB - 2019/20 There is a division of Vetoquinol called Phovia that
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 12, 2024 9:09pm
LumiHeal evaluation abstract (2018)
Interesting (short) reading for those who wants to know a little more about one of the technology acquired by Kane earlier today; LumiHeal study abstract 2018 GLTA!
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 12, 2024 5:31pm
RE:RE:RE:I wonder....
I don't think I was clear enough. Only a mind reader can know what the FDA will do, and you would have to read a bunch of minds because it is very bureaucratic and needs a bunch of people to check
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 12, 2024 5:15pm
RE:RE:I wonder....
Yo kevinOleary, long time no talk... Yup agree... but understanding the fact that we don't have control over the FDA agenda should give KNE management another reason to set the expectations a
...more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 12, 2024 5:06pm
RE:Acquistion
1. You don't get to vote on the acquisition, so your wish is iirrelevant. 2. The company doesn't have to discuss revenue and EBITDA with anyone because you won't be able to figure out it
...more
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Nov 12, 2024 3:55pm
Acquistion
Why no revenue or ebitda for FB Dermatology S.R.L disclosed? How do we know if Kane paid a fair price?
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 12, 2024 2:41pm
RE:I wonder....
The expectations that you don't like are really the estimates of how long it will take for the FDA to get it's act together and allow the acne and dispersin trials to start. kne does not
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 12, 2024 1:51pm
RE:RE:I wonder....
Very good news. We are expanding our product line, we are expanding our geographic footprint and all that at a, what seems, to be a decent cost. The most important part of it is that Dr
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >